東和薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/12/17 | 2,773 | 2,792 | 2,738 | 2,756 | -21 | -0.8% | 83,300 |
| 2024/12/16 | 2,788 | 2,798 | 2,777 | 2,777 | -11 | -0.4% | 50,600 |
| 2024/12/13 | 2,773 | 2,829 | 2,771 | 2,788 | -20 | -0.7% | 65,600 |
| 2024/12/12 | 2,817 | 2,833 | 2,801 | 2,808 | -9 | -0.3% | 47,900 |
| 2024/12/11 | 2,835 | 2,850 | 2,802 | 2,817 | -15 | -0.5% | 55,200 |
| 2024/12/10 | 2,856 | 2,857 | 2,823 | 2,832 | +8 | +0.3% | 59,500 |
| 2024/12/09 | 2,822 | 2,853 | 2,820 | 2,824 | +5 | +0.2% | 79,000 |
| 2024/12/06 | 2,872 | 2,872 | 2,819 | 2,819 | -40 | -1.4% | 44,300 |
| 2024/12/05 | 2,882 | 2,906 | 2,835 | 2,859 | -24 | -0.8% | 110,900 |
| 2024/12/04 | 2,875 | 2,896 | 2,851 | 2,883 | -17 | -0.6% | 80,600 |
| 2024/12/03 | 2,797 | 2,914 | 2,792 | 2,900 | +103 | +3.7% | 144,500 |
| 2024/12/02 | 2,802 | 2,815 | 2,781 | 2,797 | -15 | -0.5% | 86,800 |
| 2024/11/29 | 2,798 | 2,822 | 2,780 | 2,812 | +14 | +0.5% | 91,400 |
| 2024/11/28 | 2,775 | 2,798 | 2,755 | 2,798 | +28 | +1% | 92,600 |
| 2024/11/27 | 2,768 | 2,782 | 2,736 | 2,770 | +2 | +0.1% | 120,600 |
| 2024/11/26 | 2,794 | 2,811 | 2,750 | 2,768 | -32 | -1.1% | 125,000 |
| 2024/11/25 | 2,841 | 2,856 | 2,800 | 2,800 | -20 | -0.7% | 102,600 |
| 2024/11/22 | 2,815 | 2,827 | 2,796 | 2,820 | -1 | ±0% | 62,900 |
| 2024/11/21 | 2,871 | 2,884 | 2,821 | 2,821 | -6 | -0.2% | 84,000 |
| 2024/11/20 | 2,818 | 2,831 | 2,804 | 2,827 | +9 | +0.3% | 59,600 |
| 2024/11/19 | 2,858 | 2,873 | 2,807 | 2,818 | -36 | -1.3% | 66,600 |
| 2024/11/18 | 2,823 | 2,859 | 2,794 | 2,854 | +27 | +1% | 114,300 |
| 2024/11/15 | 2,900 | 2,909 | 2,827 | 2,827 | -69 | -2.4% | 97,500 |
| 2024/11/14 | 2,918 | 2,935 | 2,877 | 2,896 | -39 | -1.3% | 143,100 |
| 2024/11/13 | 3,030 | 3,055 | 2,920 | 2,935 | -165 | -5.3% | 302,000 |
| 2024/11/12 | 3,085 | 3,170 | 3,085 | 3,100 | +15 | +0.5% | 122,200 |
| 2024/11/11 | 3,120 | 3,130 | 3,065 | 3,085 | -55 | -1.8% | 86,300 |
| 2024/11/08 | 3,135 | 3,170 | 3,125 | 3,140 | +20 | +0.6% | 86,900 |
| 2024/11/07 | 3,120 | 3,145 | 3,090 | 3,120 | ±0 | ±0% | 90,500 |
| 2024/11/06 | 3,155 | 3,170 | 3,090 | 3,120 | +105 | +3.5% | 216,100 |
| 2024/11/05 | 3,085 | 3,085 | 3,000 | 3,015 | -70 | -2.3% | 82,400 |
| 2024/11/01 | 3,105 | 3,145 | 3,070 | 3,085 | -65 | -2.1% | 71,900 |
| 2024/10/31 | 3,110 | 3,150 | 3,100 | 3,150 | +55 | +1.8% | 78,300 |
| 2024/10/30 | 3,100 | 3,110 | 3,070 | 3,095 | +5 | +0.2% | 428,700 |
| 2024/10/29 | 3,090 | 3,095 | 3,040 | 3,090 | +15 | +0.5% | 59,900 |
| 2024/10/28 | 3,055 | 3,095 | 3,015 | 3,075 | +20 | +0.7% | 50,700 |
| 2024/10/25 | 3,085 | 3,095 | 3,030 | 3,055 | ±0 | ±0% | 63,100 |
| 2024/10/24 | 3,020 | 3,070 | 3,015 | 3,055 | -10 | -0.3% | 72,700 |
| 2024/10/23 | 3,080 | 3,090 | 3,055 | 3,065 | -20 | -0.6% | 51,100 |
| 2024/10/22 | 3,095 | 3,095 | 3,040 | 3,085 | ±0 | ±0% | 69,400 |
| 2024/10/21 | 3,115 | 3,115 | 3,070 | 3,085 | -45 | -1.4% | 56,700 |
| 2024/10/18 | 3,120 | 3,145 | 3,095 | 3,130 | +40 | +1.3% | 58,800 |
| 2024/10/17 | 3,085 | 3,100 | 3,070 | 3,090 | +5 | +0.2% | 48,700 |
| 2024/10/16 | 3,050 | 3,110 | 3,025 | 3,085 | +20 | +0.7% | 69,100 |
| 2024/10/15 | 3,100 | 3,130 | 3,065 | 3,065 | -35 | -1.1% | 73,700 |
| 2024/10/11 | 3,100 | 3,110 | 3,080 | 3,100 | -5 | -0.2% | 59,600 |
| 2024/10/10 | 3,090 | 3,110 | 3,065 | 3,105 | ±0 | ±0% | 40,000 |
| 2024/10/09 | 3,100 | 3,125 | 3,075 | 3,105 | -5 | -0.2% | 66,000 |
| 2024/10/08 | 3,135 | 3,170 | 3,110 | 3,110 | -65 | -2% | 63,700 |
| 2024/10/07 | 3,180 | 3,190 | 3,105 | 3,175 | +15 | +0.5% | 71,000 |
101～
150
件表示中 / 6956件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 東和薬品 | 296,700円 | +7.9% | -3.3% | 2.70% | 8.25倍 | 0.85倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| 鳥居薬 | 634,000円 | +7.1% | -35.0% | 0.00% | 52.43倍 | 1.47倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 科研薬 | 372,000円 | -6.4% | -71.8% | 5.11% | 41.43倍 | 0.92倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| ジーエヌアイ | 248,000円 | +21.7% | +999.9% | 0.00% | 10.39倍 | 3.44倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| ゼリア新薬 | 211,900円 | +3.1% | -6.5% | 2.27% | 9.83倍 | 1.04倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
